Anakinra biosimilar (Shanghai Biomabs)
阿那白滞素生物类似药（上海百迈博制药）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameAnakinra biosimilar (Shanghai Biomabs)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesShanghai Biomabs Pharmaceuticals Co LtdSunshine GuoJian Pharmaceutical (Shanghai) Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesChina National Biotec Group Co LtdShanghai Biomabs Pharmaceuticals Co LtdSunshine GuoJian Pharmaceutical (Shanghai) Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A